SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000903423-18-000400
Filing Date
2018-07-17
Accepted
2018-07-17 17:01:46
Documents
1
Period of Report
2018-07-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT glaxo-spero.html 4  
1 OWNERSHIP DOCUMENT glaxo-spero.xml 4 3540
  Complete submission text file 0000903423-18-000400.txt   5280
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Reporting) CIK: 0001131399 (see all company filings)

State of Incorp.: X0
Type: 4 | Act: 34 | File No.: 001-38266 | Film No.: 18957001
SIC: 2834 Pharmaceutical Preparations

Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Issuer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations